Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Hall

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Neurobiology of Disease|March 8, 2020
Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's diseaseJoana B Pereira, Sara Hall, Mattis Jalakas, et al.
Parkinsonism & Related Disorders|August 30, 2025
CSF markers of neuroinflammation, synaptic dysfunction and [<sup>18</sup>F]DOPA-PET in Parkinson's diseaseKevin Oliveira Hauer, Sara Hall, Adjmal Nahimi, et al.
Neuroradiology|August 9, 2015
Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsyYulia Surova, Markus Nilsson, Jimmy Lätt, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|May 10, 2024
The combined pioglitazone and topiramate therapy for management of pediatric patients with severe MASLDCallen Conroy, Aurelia Radulescu, Suzanna L Attia, et al.
Nature Aging|September 18, 2023
DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body diseaseJoana B Pereira, Atul Kumar, Sara Hall, et al.
Neuromolecular Medicine|December 11, 2012
Aβ1-15/16 as a potential diagnostic marker in neurodegenerative diseasesMagdalena Nutu, Philippe Bourgeois, Henrik Zetterberg, et al.
Biochemical and Biophysical Research Communications|December 15, 2004
The in vitro differentiation of rat neural stem cells into an insulin-expressing phenotypeChris J Burns, Stephen L Minger, Sara Hall, et al.
Pain|May 9, 2020
Differential expression of cerebrospinal fluid neuroinflammatory mediators depending on osteoarthritis pain phenotypeMartin Flores Bjurström, Mikael Bodelsson, Agneta Montgomery, et al.
Pain Reports|January 31, 2022
Central nervous system monoaminergic activity in hip osteoarthritis patients with disabling pain: associations with pain severity and central sensitizationMartin F Bjurström, Kaj Blennow, Henrik Zetterberg, et al.
Psychiatry Research. Neuroimaging|April 23, 2021
Structural and functional neuroimaging changes associated with cognitive impairment and dementia in Parkinson's diseaseConor Owens-Walton, David Jakabek, Brian D Power, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Neurobiology of Disease|March 8, 2020
Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's diseaseJoana B Pereira, Sara Hall, Mattis Jalakas, et al.
Parkinsonism & Related Disorders|August 30, 2025
CSF markers of neuroinflammation, synaptic dysfunction and [<sup>18</sup>F]DOPA-PET in Parkinson's diseaseKevin Oliveira Hauer, Sara Hall, Adjmal Nahimi, et al.
Neuroradiology|August 9, 2015
Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsyYulia Surova, Markus Nilsson, Jimmy Lätt, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|May 10, 2024
The combined pioglitazone and topiramate therapy for management of pediatric patients with severe MASLDCallen Conroy, Aurelia Radulescu, Suzanna L Attia, et al.
Nature Aging|September 18, 2023
DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body diseaseJoana B Pereira, Atul Kumar, Sara Hall, et al.
Neuromolecular Medicine|December 11, 2012
Aβ1-15/16 as a potential diagnostic marker in neurodegenerative diseasesMagdalena Nutu, Philippe Bourgeois, Henrik Zetterberg, et al.
Biochemical and Biophysical Research Communications|December 15, 2004
The in vitro differentiation of rat neural stem cells into an insulin-expressing phenotypeChris J Burns, Stephen L Minger, Sara Hall, et al.
Pain|May 9, 2020
Differential expression of cerebrospinal fluid neuroinflammatory mediators depending on osteoarthritis pain phenotypeMartin Flores Bjurström, Mikael Bodelsson, Agneta Montgomery, et al.
Pain Reports|January 31, 2022
Central nervous system monoaminergic activity in hip osteoarthritis patients with disabling pain: associations with pain severity and central sensitizationMartin F Bjurström, Kaj Blennow, Henrik Zetterberg, et al.
Psychiatry Research. Neuroimaging|April 23, 2021
Structural and functional neuroimaging changes associated with cognitive impairment and dementia in Parkinson's diseaseConor Owens-Walton, David Jakabek, Brian D Power, et al.
Pageof 6